These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30585836)

  • 21. Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency.
    Gorkom BL; Holme PA; Joch C; Rogosch T; Feussner A; McKeand W; Roberts J; van Heerde W
    Hematology; 2020 Dec; 25(1):17-25. PubMed ID: 31852380
    [No Abstract]   [Full Text] [Related]  

  • 22. Successful prophylaxis against intracranial hemorrhage using weekly administration of activated recombinant factor VII in a newborn with severe factor VII deficiency.
    Farah RA; Hamod D; Melick N; Giansily-Blaizot M; Sallah S
    J Thromb Haemost; 2007 Feb; 5(2):433-4. PubMed ID: 17109737
    [No Abstract]   [Full Text] [Related]  

  • 23. Primary prophylaxis for children with severe congenital factor VII deficiency - Clinical and laboratory assessment.
    Kuperman AA; Barg AA; Fruchtman Y; Shaoul E; Rosenberg N; Kenet G; Livnat T
    Blood Cells Mol Dis; 2017 Sep; 67():86-90. PubMed ID: 28038846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant factor VIIa prophylaxis in a patient with severe congenital factor VII deficiency.
    Tcheng WY; Donkin J; Konzal S; Wong WY
    Haemophilia; 2004 May; 10(3):295-8. PubMed ID: 15086331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rare combination: congenital factor VII deficiency with Chiari malformation.
    Bay A; Aktekin E; Erkutlu I
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):946-8. PubMed ID: 26248161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquired isolated factor VII deficiency associated with severe bleeding and successful treatment with recombinant FVIIa (NovoSeven).
    Mullighan CG; Rischbieth A; Duncan EM; Lloyd JV
    Blood Coagul Fibrinolysis; 2004 Jun; 15(4):347-51. PubMed ID: 15166922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular analysis in a patient with severe factor VII deficiency and an inhibitor: report of a novel mutation (S103G).
    Pruthi RK; Rodriguez V; Allen C; Slaby JA; Schmidt KA; Plumhoff EA
    Eur J Haematol; 2007 Oct; 79(4):354-9. PubMed ID: 17692102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of factor VII-deficient patients undergoing joint surgeries--preliminary results of locally developed treatment regimen.
    Windyga J; Zbikowski P; Ambroziak P; Baran B; Kotela I; Stefanska-Windyga E
    Haemophilia; 2013 Jan; 19(1):89-93. PubMed ID: 22845882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical efficacy and recovery levels of recombinant FVIIa (NovoSeven) in the treatment of intracranial haemorrhage in severe neonatal FVII deficiency.
    Wong WY; Huang WC; Miller R; McGinty K; Whisnant JK
    Haemophilia; 2000 Jan; 6(1):50-4. PubMed ID: 10632743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylaxis of peripartum haemorrhage using recombinant factor VIIa (rfVIIa) in pregnant women with congenital factor VII deficiency: A case report and literature review.
    Loddo A; Cornacchia S; Cane FL; Barcellona D; Marongiu F; Melis GB; Angioni S; Paoletti AM; Neri M
    Eur J Obstet Gynecol Reprod Biol; 2019 Apr; 235():77-80. PubMed ID: 30831446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new report of FVII-inhibitor in a patient suffering from severe congenital FVII deficiency.
    Borhany M; Delbes C; Giansily-Blaizot M; Zubair M; Ahmed MS; Fatima N; Shamsi T
    Haemophilia; 2015 Jul; 21(4):e336-8. PubMed ID: 25955166
    [No Abstract]   [Full Text] [Related]  

  • 32. Prophylactic effect of recombinant factor VIIa in factor VII deficient patients.
    Mathijssen NC; Masereeuw R; Verbeek K; Lavergne JM; Costa JM; van Heerde WL; Nováková IR
    Br J Haematol; 2004 May; 125(4):494-9. PubMed ID: 15142120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of Labour and Delivery in a Patient With Acquired Factor VII Deficiency With Inhibitor: A Case Report.
    Matei A; Dolan S; Andrews J; Rivard GÉ
    J Obstet Gynaecol Can; 2016 Feb; 38(2):160-3. PubMed ID: 27032741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term follow-up of prophylaxis with recombinant activated factor VII in patients with congenital factor VII deficiency.
    Jenabali Jahromi B; Karimi M
    Haemophilia; 2011 Jul; 17(4):713-5. PubMed ID: 21299748
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prophylactic use of a recombinant activated factor VII in delivery haemorrhage by caesarean in a woman with major factor VII deficiency: a case report].
    Comes JF; Devignes J; Thiebaugeorges O; Briquel ME; Lecompte T
    Ann Biol Clin (Paris); 2011; 69(6):713-9. PubMed ID: 22123573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicenter, observational study to evaluate hemostasis following recombinant activated FVII treatment in patients in Japan with congenital factor VII deficiency.
    Seita I; Kinai E
    Blood Coagul Fibrinolysis; 2023 Jul; 34(5):295-304. PubMed ID: 37395185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgery in patients with congenital factor VII deficiency - a single center study.
    Szczepanik A; Wiszniewski A; Oses-Szczepanik A; Dąbrowski W; Pielaciński K; Misiak A
    Pol Przegl Chir; 2018 May; 90(5):1-5. PubMed ID: 30426948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison between recombinant activated factor VII (Aryoseven) and Novoseven in patients with congenital factor VII deficiency.
    Faranoush M; Abolghasemi H; Toogeh G; Karimi M; Eshghi P; Managhchi M; Hoorfar H; Dehdezi BK; Mehrvar A; Khoeiny B; Kamyar K; Heshmat R; Baghaeipour MR; Mirbehbahani NB; Fayazfar R; Ahmadinejad M; Naderi M
    Clin Appl Thromb Hemost; 2015 Nov; 21(8):724-8. PubMed ID: 24651301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous infusion of recombinant activated factor VII during caesarean section delivery in a patient with congenital factor VII deficiency.
    Jiménez-Yuste V; Villar A; Morado M; Canales M; Hernández MC; Sanjurjo MJ; Quintana M; Hernández-Navarro F
    Haemophilia; 2000 Sep; 6(5):588-90. PubMed ID: 11012708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenicity of activated recombinant factor VII followed through nine years of clinical experience.
    Nicolaisen EM
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S119-23. PubMed ID: 9819042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.